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ABREVIATIONS 
 
Ab  Antibody 
APS  Ammonium persulfate 
Bcl-2  B cell lymphoma 2 
BCA  Bicinchoninic acid 
BCR  B cell receptor 
bp  basepair 
BSA  Bovin serum albumin 
CD  Cluster of differentiation 
ConA  Concanavalin A 
ER  Endoplasmatic reticulum 
FACS  Fluorescence activated cell sorting 
FCS  Fœtal calf serum 
FITC  Fluoresceine isothiocyanate 
IL  Interleukin 
ITAM  Immunoreceptor tyrosine-based activation motif 
kDa  Kilo Dalton 
kHz  Kilo Herz 
L-Asn  L-Asparagin 
LEAF  low endotoxin, azide free 
LPS  Lipopolysaccharide 
MEF  Mouse embryo fibroblast 
MW  Molecular weight 
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
PI  Propidium iodide 
P/S  Penicillin & Streptomycin 
PS  Phospatidylserine 
SCF  Stem cell factor 
SDS  Sodium dodecyl sulfate 
TCR  T cell receptor 
TEMED  Tetramethylethylenediamine 
WT  Wildtype 
2ME  2-Mercaptoethanol 
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1 INTRODUCTION 
 
1.1 Apoptosis in general 
The term apoptosis comes from the Greek and means "falling leaves of a tree”. This 
natural and physiological phenomenon is essential for the proper functioning of a 
living organism. It is found both during embryogenesis and in the regression of the 
tail of the young frog. The mechanism of apoptosis also governs the cell death in 
order to shape the fingers and feet. It is also responsible of the elimination of nearly 
95% of immature immune cells during T cell development in the thymus. [1] In other 
cases, aberrant regulation of apoptosis can result in a pathological event. When the 
balance between cell proliferation and apoptosis is broken, the disruption of the cell 
can lead to either an overactive apoptosis (autoimmune diseases, e.g. type I 
diabetes, neurodegenerative diseases like Alzheimer, Huntington's, Parkinson's) or 
conversely to an inhibited apoptotic activity (cancers, autoimmune diseases…). 
The mechanism of apoptosis, also called programmed cell death, results in a 
cascade of enzymatic reactions that leads to physiological changes in cells such as 
decrease and condensation of the nucleus and cytoplasm, fragmentation of DNA. 
The cytoplasm is filled with vesicles and surface deformation is observed. [2] Another 
feature is observed on a microscopic level on the surface of the membrane, as 
phosphatidylserine (PS), a lipid initially present on the inner side of cell membrane, is 
expressed on the cell surface (flip-flop phenomenon). This gives possibility to 
differentiate apoptotic cells and healthy cells by labelling with Annexin V (Figure 1), a 
protein binding to PS. [1] At this stage, in vivo, the dead cell is phagocytosed by 
macrophages. Moreover, unlike necrosis, the cell membranes of apoptotic cells do 
not get ruptured, causing no damage to surrounding healthy cells and no 
inflammation.  
 
Figure 1 : During apoptosis, phosphatidylserine (PS) externalization is observed (represented here with 
red head) Annexin V which has affinity for PS can bind to them. By microscopy or flow cytometry, 
apoptotic cells can thus be easily differentiated from viable cells [3] 
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Currently, two distinct pathways (Figure 2) are known to drive a cell to caspase 
activation, which are the key effector proteases of apoptosis. Importantly, both 
pathways culminate in the activation of the same set of effector caspases:  
 The intrinsic pathway, also known as mitochondrial or stress-induced pathway. It 
is governed primarily by the proteins of the Bcl-2 family which regulates the 
permeability of the outer membrane of mitochondria. It is triggered by many 
cytotoxic factors such as viral infections, DNA damage and growth-factor 
deprivation.[4]  
 
 The second possibility is the extrinsic pathway or death receptor pathway. In this 
case, a ligand binds so called death receptors on the cell surface, which then 
triggers the apoptotic cascade. 
 
 
Figure 2 : Schema of different possible pathways in apoptosis (intrinsec and extrinsec pathways) [5]  
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1.2 The Bcl-2 family 
The proto-oncogene Bcl-2 was identified for the first time in a follicular lymphoma 
type B with a translocation t(14;18). This protein family consists of at least 20 
members. It is characterized by structures called Bcl-2 homology domain (BH) and 
each of them has at least one. In addition, most have a transmembrane domain to 
span the outer membrane of mitochondria (OMM), and thus regulate cell death. Bcl-2 
proteins can also be found on the membrane of endoplasmatic reticulum (ER) and 
even on the external nuclear membrane.  
A classification of the proteins was carried out according to their role in apoptosis. 
Activation of the pro-apoptotic proteins (e.g. Bax, Bak, Bok, Bad, Bid and Bim) 
induces the permeabilization of the OMM, drop in mitochondrial membrane potential 
and releases of the cytochrome c into the cytosol. Cyt. c is needed to trigger the 
apoptotic cascade. The anti-apoptotic (e.g. Bcl-2, Bcl-xL, Mcl-1, A1 and Bcl-2) are 
antagonists which directly neutralize the action of pro-apoptotic Bcl-2 family members 
and strongly inhibit apoptosis when over expressed. This is the reason why many 
chemotherapy resistant cancer cells heavily over express anti-apoptotic Bcl-2 
proteins. [6][7][8] 
 
Figure 3 : Structure of the two different groups (anti-apoptotic and pro-apoptotic proteins) of Bcl-2 family 
[9] 
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1.3 Bok 
Bok belongs to the family of proteins Bcl-2 and especially of the pro-apoptotic group. 
Its structure contains three Bcl-2 homology domains (BH1-3) necessary for the 
dimerization of the protein and a C-terminal transmembrane region which allows 
anchorage to the ER and mitochondrial membranes. [10]  
 
Figure 4 : Structure of pro-apoptotic proteins of the Bcl-2 family [11] 
 
Thus Bok looks very similar to Bax and Bak, two other members of this subgroup 
(Figure 4). Originally reported to be expressed mainly in the reproductive tissues 
(ovary, testis and uterus) [10], it is now clear that Bok is expressed in most tissues 
and cell type. However, its exact role is unknown. Indeed, recently discovered, much 
research is currently underway to determine precisely its function in the cell. This 
analysis is now facilitated by a recently developed bok-deficient mouse model 
(Kaufmann & Strasser, submitted).  
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1.4 Flow cytometry (FACS) 
Flow cytometry (Figure 5) is an analytical 
method widely used in biomedical research. At 
the forefront of technology, it allows the 
detection of cells with monoclonal antibodies 
coupled to fluorochromes (Appendix 7). The 
antibody bound to the antigen of the cell of 
interest will issue a subsequent fluorescence to 
a specific wavelength in response to an 
excitation laser. For optimum performance, this 
unit was designed in 3 main parts. (Figure 6) 
A fluid system transports the suspension of 
labeled cells in a liquid stream prior to the light 
source. The cells are then excited by the laser 
(optical part). Therefore, the cells emit fluorescence in turn corresponds to the 
wavelength of the fluorochromes attached to the surface. Converted into electronic 
signals and then digitized by the electronic system, they can be analyzed graphically 
by the operator [12]. 
 
 
 
Figure 6 : Schema of the three main parts constituting flow cytometer: fluidic, optic and electronic system 
[13]  
Figure 5 : Picture of the flow cytometry 
system (FacsCalibur, BD Biosciences) 
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This instrument has a wide field of action. It confers many significant advantages 
such as the quantification of DNA content and used primarily in cancer’s cytogenetic 
[14]. It is particularly characterized by its scanning speed average of 1000 cells per 
second depending on the model and its versatility allows you to work simultaneously 
on several parameters of a population while analyzing the cells individually. 
Moreover, its detection sensitivity and statistical significance of counting made him a 
major advantage over conventional optical microscopy. 
 
APPLICATION 
 
Many applications of flow cytometry are now used in biomedical research, such as 
characterization of cellular subsets by cells surface staining, DNA count to determine 
the distribution of cell cycle phases, determination of cell viability with Annexin-V/PI 
or determining total cell numbers by the use of FACS reference beads. Each of the 
methods mentioned allows a different analysis of the cells on the same instrument. 
 
Surface staining 
The surface staining allows the identification and distinction of cell types among the 
most used in the biomedical field. As each cell has its own set of surface antigens 
staining with specific monoclonal antibodies can identify those by FACS analysis. For 
example, monitoring of the blood of HIV patient, where a drop in T helper cells (CD4+ 
T cells) is observed, is one of the applications. In this practical work, this application 
will be particularly used to differentiate the CD45.1 and CD45.2 loci in the experiment 
of mast cells competition. (Figure 7) 
 
 
Figure 7 : Scattergram (also called dot plot) representing mast cells competition results. At T0, 56% of 
viable cells are CD45.2 positive (using FITC-labeled anti-CD45.2), 43.3% are CD45.1 positive (using PE-
labeled anti-CD45.1). 
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Cell cycle and DNA damage 
During cell renewal or development of a living organism, a whole series of steps must 
be respected to allow optimal cell division. The cell cycle also called generation time 
is the time taken to proceed from one cell division to the next [15]. The eukaryotic cell 
cycle can be divided in two main parts: Interphase and mitosis (M phase). Interphase 
is composed of three sub phases: G1, S and G2 whereas in the mitosis phase, 
duplicated chromosomes are segregated to give rise to two daughter cells. During 
the G1 phase, cells prepare intracellular components for the replication of the 
genome that will take place during the S phase. The same happens in the G2 phase 
to allow the cell to enter the M phase. 
 
The amount of intracellular DNA can be used to accurately quantify the proportion of 
cells in each stage of the cell cycle. After the rupture of the outer cell membrane by 
the addition of a hypotonic buffer (as well as digestion of all RNA entities with RNAse 
A, thereby reducing background noise), the detection of DNA is possible with 
propidium iodide, an intercalating agent that has particular affinity for DNA. Flow 
cytometry supports this kind of analysis and fluorescence is directly proportional to 
the amount of genomic DNA. Results can be plotted as a histogram (Figure 8). 
Furthermore, this method can also be used to quantify the percentage of dead cells, 
as their fragmented genomic DNA will be found in the subG1 peak (< 2N) in a 
histogram. 
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Figure 8 : Example of histogram depicting phases of the cell cycle. This graph is realized with the FlowJo 
software. Mast cells were incubated during 72h in the presence of 1µg/mL etoposide. The first graph 
represents ungated cells before separating cells in two groups with less than 2n or more or equal to 2n 
chromosome content. Viable cells are then gated and finally histogram with 3 phases (G1, S and G2/M) is 
shown on histogram. 
 
 
Cells survival 
In addition, the work of basic research is much facilitated by the differentiation 
between viable, early apoptotic and late apoptotic (secondary necrotic) cells. Cells 
are stained with Annexin V and propidium iodide, allowing the identification of the 
state of life or death of the cell. The result after flow cytometry is expressed in form of 
a scattergram (also called dot plot), as shown in Figure 9. 
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Figure 9 : AnnexinV/PI scattergram of CD8 lymphocytes after cultivation in the absence of cytokines for 
24 hours 
 
A recent study has shown, however, the limitations related to the Annexin V / PI 
double staining. Indeed, an overestimation of the number of apoptotic cells is 
possible if the binding of fluorochrome on double-stranded RNA rather than DNA 
fragmentation. To avoid this disagreement, pretreatment with RNase is highly 
recommended. [16]  
 
Counting cells with reference beads 
This method determines directly the absolute count of any leucocytes population with 
low variability. A defined number of polystyrene FITC-labeled FACS reference beads 
is added to the sample containing cells of interest. Besides FITC-labeling the beads 
are very small and have a high side scatter profile, making it easy to distinguish them 
from cells. After analysis by flow cytometry, a ratio between the number of viable 
cells counted (PI exclusion) and the number of beads added will be calculated. In this 
example (Figure 10), the total number of cells in sample is calculated like this:  
 
 
 
 
 
Number of beads per well :  8’000 
Number of counted cells :  4082 
Number of counted beads :  560 
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Figure 10 : Example of FACS analysis with reference beads for WT CD4 cells. Data were analyzed by 
Weasel 1.2.2 software. R0 gating represents reference beads and R1 viable cells. 
 
Cells isolation 
Cell separation can be performed by FACS using a FACS sorter. Cell separation at 
the output of the controller is done with purity levels exceeding 99% but this 
application is slow (one hour to sort 10 million cells) and requires some experience. 
In this work, separations with magnetic beads are used. This is a newer and cheaper 
technique based on the conjugation of the ligand (e.g. antibody) to magnetic 
particles. [17] An antibody attached to the surface of magnetic beads allows labeling 
and magnetic separation of wanted (Figure 11). Thanks to the magnetism principle, 
the beads coupled to the cells (positive fraction) will be retained on the tube wall and 
thus recovered after removing the remaining solution containing the cells constituting 
the so-called negative fraction. 
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Figure 11 : Schematic representation of the immunomagnetic purification of B by negative selection. After 
splenectomy, cells were washed and incubated with a cocktail of antibodies labeling all splenocytes 
except B cells. Since the B cells do not bind any of the antibodies present in the cocktail, they will not be 
retained on the magnetic wall and will be present in the negative fraction highly enriched for B cells. [18]  
 
 
This application can for example be used for allo- and autografts when it comes to 
selecting hematopoietic progenitors expressing the CD34 surface molecule which is 
the marker of stem cells [19]. In this work, it allows to obtain pure CD4+ or CD8+ T cell 
fractions (positive sort using an anti-CD4 or anti-CD8 antibody, respectively) and to 
obtain purified B cells by negative selection, all directly from the mouse spleen. 
According to the manufacturer (BD Biosciences), a purity of about 98% is obtained 
for the positive fraction and > 90% for the negative fraction. 
 
This system is inexpensive and relatively simple. It still requires a long process of 
purification of the initial mixture. To cite just one step, the lysis of red blood cells is 
one of the most critical steps for the proper functioning of the assay. In addition and if 
possible, negative sorts (labeling and eliminating all the unwanted cells) is preferable 
to positive sorts, where the wanted cells are more manipulated by labeling with 
antibodies, which may trigger activation of cells or increased cell death. 
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1.5 Activation of T and B cells 
 
T and B lymphocytes are part of the leukocytes, immune cells present in all 
mammals. They play a role in host defense. Membrane structure and particularly 
their receptor called T cell receptor (TCR) for T cells and B Cell Receptor (BCR) in B 
cells can recognize antigens. This characteristic allows the activation of these cells in 
vivo and in vitro with antigens or other activating factors. 
 
 
Figure 12 : B cell receptor structure with two co-receptor Ig and Igβ (left picture) and T cell Receptor 
structure with signaling complexe (CD3, dimere Zeta). ITAM: Immunoreceptor tyrosine-based Activation 
Motif [20]  
 
Activation of resting B cells and T cells leads to highly stimulated and proliferating 
cells, called B or T lymphoblasts. A net increase in their cytoplasmic contents as well 
as in overall cellular size can be observed. To activate T cells, concanavalin A (Con 
A) extracted from Jack Beans can be used and shows spectacular results for CD4+ 
and CD8+ T cells after 72 hours already. Stimulation with precoated anti-CD3 and a 
mix of anti-CD3/CD28 antibodies also give great results but is much more expensive 
than ConA. T cell blasts heavily depend on the cytokine Interleukin 2 (IL-2) for 
growth. Activated B cells need IL-2, IL-4 and IL-5 and are generally more difficult to 
cultivate in vitro than T cells. We can activate B cells using bacterial 
lipopolysaccaride (LPS) which is also necessary for growth and proliferation of these 
cells, probably due to its non-specific mitogenic power that drive them to the cells 
division rather than cells differentiation. [21]  
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2 AIM OF THE BACHELOR THESIS 
 
Bok is a member of the Bcl-2 family and therein is part of the pro-apoptotic subgroup. 
Newly discovered, its exact role and function in apoptosis or other biological 
processes remain largely unknown. Besides its clear roles in regulating cell death, 
Bok has also been proposed to regulate cell cycle arrest and proliferation; but those 
experiments were only carried out in human cancer cell lines. Using bok-deficient 
cells, i.e. cells derived from a genetically manipulated mouse lacking the bok gene, is 
will help to understanding the mechanisms of Bok function. The following 
experiments, carried out during 16 weeks of this Bachelor thesis, are structured 
around the following main points 
 
Colony forming assay 
The aim of this experiment is to look for long-term protective effects in bok-/- MEFs 
compared to wildtype controls upon addition of apoptotic stress stimuli (DNA damage 
or replicative stress).  
 
Direct competition growth assay in bone marrow derived mast cells 
According to previous data in the Kaufmann lab bok-/- mast cells grow slower than 
WT cells when cultured in vitro (in separate wells). Now, experiments will be 
performed with respect to cell growth and cell survival if WT and bok-/- are mixed 
together in the same wells. 
 
T and B cell work 
The differences in activation in vitro, as measured by increase in cell size 
modification and fold increase in total cell number, will be compared between bok-
deficient and WT CD4+ T cells, CD8+ T cells and B cells.. Furthermore, differences 
in cell cycle arrest upon DNA damage will be evaluated by FACS analysis, (Hypo PI 
profiling) and anti-Bok Western blotting of activated T and B cells performed. 
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3 MATERIALS AND METHODS 
 
Methods used for all these experiments are described in Appendix 1. During this 
project, cells were isolated from organs dissected from 8 to 14 weeks old male or 
female C57BL/6 WT and bok-deficient (bok-/-) mice. They were housed in individually 
ventilated cages (IVC) at the 'Zentrale Tierställe' of the Inselspital (Bern, CH). 
Regarding statistical analysis, the results are represented as mean +/- standard 
deviation (SD). Values from different experiments were compared using the Student’s 
t test. Significance was defined for p values <0.05. 
3.1 Media 
 
Complete DMEM Medium 
DMEM/Glutamax 4.5 g/L D-glucose with Pyruvate (Invitrogen), supplemented with 
5% fetal calf serum (FCS, PAA Clone) and 1% Penicillin/Streptomycin (100x solution, 
Invitrogen) 
 
FMA Medium 
RPMI 1640 + glutaMAXTM-1 (Invitrogen) supplemented with 10% fetal calf serum 
(FCS) (PAA Clone), 1% Penicillin/Streptomycin (P/S) (100x solution, Invitrogen), 
50µM 2-Mercaptoethanol (5000x stock (250mM), Sigma) and 250µM L-Asparagin 
(100x stock (25mM), Sigma) 
 
Freezing Medium 
90% fetal calf serum (FCS, PAA Clone) + 10% DMSO (Sigma) 
 
RPMI 1640 Medium 
RPMI 1640 + glutaMAXTM Medium (Invitrogen) supplemented with 10% fetal calf 
serum (FCS, PAA Clone), 1% Penicillin/Streptomycin (P/S) (100x solution, 
Invitrogen), 50µM 2-Mercaptoethanol (Sigma) and 10% of IL-3 conditioned WEHI-3B 
medium as a source of murine IL3. 
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3.2 PCR 
 
Cells 
Tail biopsies from two C57BL/6 and one bok-/- mouse were collected from sacrificed 
animals. 
 
Genomic DNA extraction 
Genomic DNA was purified from mouse tail biopsies using 500 l of tail lyses buffer 
and 25 l of Proteinase K (20 mg/ml; Roche) to digest them overnight at 56°C in an 
Eppendorf thermomixer at 650rpm. The digest was centrifuged at 13000rpm during 5 
minutes and 450 µl of the cleared supernatant transferred to a new Eppendorf tube. 
Genomic DNA was precipitated by addition of 500µl isopropanol (Sigma) and 
subsequently centrifuged at13000rpm for 15 minutes. The DNA pellet was washed 
once with 500µl of 70% ethanol (Merck/Grogg) and let to dry upside down. The dry 
DNA pellets were resuspended in 150µl of TE Buffer (pH 8.0) by incubated at 37°C 
during 30 minutes or overnight at room temperature. Before using samples for PCR 
reaction, genomic DNA was well vortexed. 
 
Bok-/- genotyping using a 3-primer PCR based reaction 
1 µL of purified genomic DNA template was used per reaction. Note that the 'Green 
Mix' is ready to use and contains everything required for PCR apart from the DNA 
template and the primers (i.e buffer, dNTP mix, Taq polymerase), and further already 
includes the loading buffer/dye for subsequent agarose gel electrophoresis.  
 
 
 
Figure 13 : Structure of the primers used for genotyping 
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The master mix was prepared as follows: 
 
Table 1 : Mastermix for 7 PCR reactions for a final volume of 25µl 
Reagents 
Reagents volume  
for 1 reaction 
[µl] 
Reagents volume  
for 7 reaction 
[µl] 
Green Mix 20 140 
Primer bok 17 [10µM] 2 14 
Primer bok 18 [10µM] 1 7 
Primer bok 20 [10µM] 1 7 
 
All amplification reactions were carried out in a total volume of 25 μL. The cycling 
parameters for PCR were as follows: a preincubation step at 94°C for 2 minutes then 
35 cycles were performed as follows: denaturation at 94°C for 30 seconds, annealing 
at 55°C for 30 seconds and extension at 72°C for 45 seconds. PCR products were 
stored at 4°C until analysis. A negative sample called negative control was included 
by replacing the DNA template by water. Three positive controls were added to the 
samples to confirm the location of bands on the gel. The size of the WT allele is 150 
bp and the size of the mutated (deleted) bok allele of 383 bp. 
 
Analysis of the amplification product 
The DNA fragments obtained following PCR were analyzed by agarose gel 
electrophoresis. For direct analysis of the fragments, the amplified PCR products 
were loaded on a 2 % agarose gels. Electrophoresis was performed in TAE buffer for 
about 2 hours at 80V, and the DNA was visualized on an ultraviolet transilluminator 
following RedSafeTM (IntRON biotechnology) staining. The size of the amplified 
fragments was estimated by comparison to a 100 bp ladder marker set (Fermentas). 
 
Reagents 
 Agarose       Sigma Aldrich 
 Ethanol 100%      Sigma Aldrich 
 Isopropanol 100%      Sigma Aldrich 
 GeneRuler 100pb DNA Ladder PLUS, SM0321/2/3 Fermentas 
 Primers TK bok 17      Sigma Aldrich 
 Primers TK bok 18      Sigma Aldrich 
 Primers TK bok 20      Sigma Aldrich 
 Proteinase K , stock 10mg/mL    Roche 
 RedSafeTM       IntRON biotechnology 
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3.3 Colony forming assay in SV40 Large T antigen (LT) 
immortalized mouse embryo fibroblasts (MEF) 
 
Cells 
Multiple independent SV40 LT Ag immortalized MEF lines; each derived from a 
different embryo: 4 for WT (E4, E5, E6 and CB) and 3 for bok-/- (E2, E5 and E9).  
 
Experiment 
1x103 mouse embryo fibroblasts were seeded per well in 6-well culture plate 
(CellStar®, Greiner Bio-one) in a volume of 2mL complete DMEM Medium. After a 
minimum of 2 hours to let the cells attach to the plates, apoptotic stress stimuli were 
added, including endoplasmatic reticulum-stress inducers Tunicamycin (Enzo 
LifeSciences), Thapsigargin (Enzo LifeSciences) and Brefeldin A (Sigma Aldrich),  as 
well as the DNA damage inducing agents Etoposide (Ebewe, Pharmacy Inselspital), 
hydroxyurea (Sigma Aldrich) and irradiation with UVB (UVB Stratalinker 1800, 
Stratagene),. After 7 to 8 days of incubation at 37°C for primary MEF and 6 to 7 days 
for SV40 MEF, cells were washed with PBS (pH 7.4), fixed with 1mL cold ethanol 
70% (Sigma Aldrich) for 5 minutes on ice and then stained with 2mL of a 0.1% 
Crystal Violet solution (Sigma Aldrich) under slow agitation. Finally cells were washed 
with 1mL ddH2O and air-dried. Counting of cells was realized manually upon a white 
light table and the following formula was used to calculate percentage of cells: 
 
 
           Equation 1 
 
 
Reagents 
 Brefeldin A 5mg/mL Sigma 
 Crystal violet   Sigma Aldrich 
 Gentamicin   Sigma 
 Ethanol 100%:   Sigma Aldrich 
 Etoposide 20mg/mL Ebewe, Pharmacy Inselspital 
 Hydroxyurea 500mM Sigma Aldrich 
 Dulbecco’s PBS 1x  PAA Laboratories GmbH 
 Thapsigargin 1mM  Enzo LifeSciences 
 Trypsin-EDTA 1x  Invitrogen 
 Tunicamycin 10mg/mL Enzo LifeSciences 
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3.4 Direct competition growth of bone marrow derived mast cells 
 
Cells 
Three mast cells lines were differentiated ex vivo from total bone marrow isolated 
from the femur of C57BL/6 WT (CD45.1), WT (CD45.2) and bok-/- (CD45.2) mice. 
Aliquots of primary bone marrow were frozen in liquid nitrogen at -196°C in 1mL of 
Freezing Media (90% FCS + 10% DMSO) for future use. 
 
Cultivation of mast cells 
Bone Marrow cells were quickly thawed, washed once in prewarmed PBS and 
plated at a density of 0.5-1 x106 cells/ml in RPMI1640 Medium (Invitrogen). Fresh 
medium was added weekly for 3 weeks and suspension cells placed in new wells in 
order to eliminate unwanted adherent cells. After 4 weeks of culture, 10% of stem cell 
factor (SCF) conditioned medium (derived from CHO/muSCF cell line) was added to 
the culture to increase proliferation of mast cells. Cells were subsequently maintained 
in complete RPMI1640 medium plus 10% of IL-3 and 10% SCF. Established mast 
cell lines could be used for experiments approx 4 weeks before they stopped to grow.  
 
Experiment 
All results are derived from cells that had been in culture for less than 4 weeks after 
full maturation of mast cells. 1:1 Mixes between 2.5x104 WT(CD45.1) and 2.5x104 
WT(CD45.2) mast cells as well as 2.5x104 WT(CD45.1) and 2.5x104 bok-/- (CD45.2) 
mast cells were prepared in 48-well plates (CellStar®, Greiner Bio-one), in a total 
volume of 1 mL Limiting concentrations of cytokines, i.e.10%, 1% and 0.1% of each, 
IL3 and SCF were tested.  The percentages of CD45.1- and CD45.2-positive cells 
were quantified over time by flow cytometry (FACS). 
 
Flow cytometric analysis 
At each time point (including t=0 h), the cells were transferred to a 5mL FACS tube, 
topped with FACS Buffer (buffered saline solution + 2% FCS + 10mM NaN3), spun at 
1500 rpm for 5 min at 4°C and decanted. The cells were then stained in a total 
volume of 100 µl (20 min on ice, in the dark) with an anti-CD45.1-PE (1/500) and an 
anti-CD45.2-FITC (1/500) antibody, diluted in FACS Buffer + 1% normal rat serum 
(NRE) + 10% hybridoma supernatant of FcγRII/III blocking antibody (antiCD16/CD32, 
clone 2.4G2)). Cells were washed with FACS buffer and resuspended in 200µl of 
FACS buffer plus 2 µg/mL propidium iodide (PI, Sigma Aldrich) and analyzed on a 
flow cytometer (BD FACS CaliburTM). Data were analyzed by Weasel 1.2.2 software. 
 
Reagents 
 Ab mouse anti-CD45.1-PE, Clone A20, 0.20 mg/mL Biolegend 
 Ab mouse anti-CD45.2-FITC, Clone 104, 0.50 mg/mL Biolegend 
 Normal Rat serum (NRS) Promocell 
 Propidium iodide (PI), stock 500µg/mL Sigma Aldrich 
 Blocking antibody Anti-FcγRII/III HB-197 hybridoma cell supernatant  
 Clone 2.4G2 
 SCF CHO/muSCF conditioned supernatant 
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3.5 Mast cells HYPO PI cell cycle analysis 
 
Cells 
Mast cells were differentiated ex vivo from murine bone marrow as described 
earlier. Tree mast cell lines were used for this experiment: WT CD45.1, WT CD45.2 
and bok-/- CD45.2; all of which are on a C57BL/6 genetic background 
 
Experiment 
1x105 Mast cells were cultured in the presence or absence of apoptotic stress 
(etoposide, 1, 0.5 and 0.1µg/mL) in 48-wells culture plates in a final volume of 1mL of 
complete RPMI 1640 Medium. . After 48 or 72 h cells were harvested and analyzed 
for cell cycle distribution as described below. 
 
Cell cycle analysis by flow cytometry 
The percentage of Mast cells in G0/G1, S and G2/M phase of the cell cycle after 
treatment with different concentrations of etoposide (Ebewe, Pharmacy Inselspital) 
was determined by “hypotonic PI Buffer” staining, as described above for T and B 
cells  
 
Reagents 
 Etoposide "Ebewe"   Inselpital Pharmacy 
 Tween-20    Sigma Aldrich 
 RNAse A, DNAse inactivated AppliChem  
 PI     Sigma Aldrich 
 IL3     WEHI-3B conditioned supernatant 
 Dulbecco’s PBS 1x   PAA Laboratories GmbH 
 SCF     conditioned medium from CHO/muSCF cells 
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3.6 T and B cell activation 
 
Cells  
T and B lymphocytes were purified from the spleen of C57BL/6 WT and bok-/- mice. 
 
B cell-enrichment from Murine Spleen by Magnetic Bead Sorting 
Splenic B cells were purified using magnetic bead based cell separation technology 
(BD IMagTM, BD BioSciences). The spleen was surgically excised from sacrificed 
mice and a single cell suspension was prepared using a 70 µl cell strainer (BD 
Biosciences). After lysing of red blood cells with 1x red cell removal buffer (150mM 
NH4Cl, 12mM NaHCO3, 0.1mM EDTA), mouse B lymphocyte enrichment antibody 
cocktail (BD BioSciences) were added to cells and negative magnetic sort performed 
following the manufacturer's protocol (BD Biosciences). The resulting negative 
fraction, consisting of a highly purified resting B cell population, was used for 
subsequent experiments. Viable cells were resuspended in FMA Medium 
(Invitrogen). 
 
Magnetic Labeling and Separation of CD4+ and CD8+ T cells from Murine 
Spleen 
A splenic single cell suspension was prepared as described above. CD4+ and 
CD8+ T cells were isolated by positive sorting following the manufacturer's 
instructions (BD Biosciences). Purified T cells were resuspended in FMA Medium 
and cells were counted using a Neubauer chamber diluting (10-20*106 cells/mL) and 
Trypan blue to exclude dead cells. 
 
B Cell Activation 
B cells (2.5x104) were cultured in a total of 200µL per well (96 well plate) in FMA 
Medium and activation followed up to 6 days. B cells were activated with either 
20µg/mL lipopolysaccarides (Sigma Aldrich) or with 20µg/mL monoclonal anti-mouse 
anti-IgM (Jackson ImmunoResearch), all in the presence of 10ng/mL IL-2, 50ng/mL 
IL-4 and 50ng/mL IL-5 (all recombinant cytokines, Peprotech).  
 
T Cell Activation 
T cells (2.5x104) were incubated in a total of 200µL in FMA Medium in 96-well 
culture plates (CellStar®, Greiner Bio-one) and activation followed up to 7 days. T 
cells were activated with either 2 µg/mL Concanavalin A (ConA) (Sigma), with 10 
µg/mL pre-coated anti-CD3 (Clone 145-2C11, Stock 1mg/ mL, low endotoxin azide 
free, LEAF) or 10 µg/mL pre-coated anti-CD3 plus 10 µg/mL pre-coated anti-CD28 
(Clone 37.S1, Stock 1mg/ mL, LEAF), in the presence of 10ng/mL of IL-2 (Peprotech)  
 
Large Scale T Cell Activation 
Purified CD4+ or CD8+ T cells were seeded in a total volume of 5 mL in25 cm2 
flasks at a density of 2*106 cells/mL in FMA Medium in the presence of 2µg/mL 
Concanavalin A (Sigma Aldrich) and 10 ng/mL IL2 (Peprotech). The cultures were 
incubated at 37°C in a humidified atmosphere of 5% CO2 in air for 3 days. 
Concanavalin A was then removed by at least 3 wash steps with PBS. Activated T 
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cells were seeded at 5-10x104 cells/ml and expanded for 2-3 more days in the 
presence of 10 ng/mL IL2  
 
Determination of viable cell number using FACS reference beads 
Cells were harvested into FACS tubes and 100µl of FACS buffer containing 8000 
FITC-labeled FACS reference beads (Invitrogen) added (1xKDS.BSS + 2% FCS + 
10mM NaN3 + 8x10
4 FACS reference beads/mL + 4µg/mL PI). Cells were then 
analyzed by flow cytometry on a FACS instrument (FACSCalibur, BD BioSciences). 
To obtain the total number of cells in sample, the following formula was used 
(Equation 2). Data were analyzed by Weasel 1.2.2 software. 
 
 
           Equation 2 
 
 
Cell cycle analysis 
The percentages of B and T cells in G0/G1,S and G2/M phase of the cell cycle after 
treatment with different concentrations of etoposide (0.5 µg/mL, 1.0 µg/mL, 2.5 
µg/mL, 5 µg/mL, 10 µg/mL) was determined by hypotonic propidium iodide (PI) 
staining of genomic DNA content. Cells were lysed in 200µl of hypotonic PI Buffer 
(0.1% sodium citrate, 0.03% Tween-20, 25 µg/ml RNAse A and 50 µg/mL PI) for at 
least 30 minutes on ice in the dark. Cells were analyzed in a FACS at a flow rate of 
<200 events/second and PI staining intensity was plotted on a linear scale (FL2A). 
Cell-cycle profiles were analyzed using the Weasel 1.2.2 software and FlowJo 
software (Dean Jett Fox model) after exclusion of cellular doublets and dead cells 
(subG1). 
 
Quantification of Cell Viability 
Viability of B cells was assessed by FACS by exclusion of propidium iodide (PI) 
(Sigma) and absence of cell-surface staining with EGFP-labeled AnnexinV (self-
made). At least 5x104 cells were incubated in Ca2+ containing FACS buffer with 
GFP-AnnexinV (ca 0-5 µg/mL) for 20 min on ice in the dark. Cells were washed 1x 
and then resuspended in 200 µL FACS buffer containing 2 µg/ml PI. 
 
Freezing of cells 
1-5x106 B cells were centrifuged at 1500 rpm during 5 minutes at 4°C, washed and 
resuspended in 1mL of freezing medium and transferred to cryovials. Before cells 
were stocked in liquid nitrogen at -196°C, tubes were put at -80°C in a freezing box 
containing isopropanol (Sigma) to make sure cells were cooled down at a constant 
optimal rate of 1 grade Kelvin per hours. 
 
Reagents 
 Monoclonal anti-mouse CD3    Stock 1mg/mL   
Clone 145-2C11 
BioLegend 
 Monoclonal anti- mouse CD28    Stock 1mg/mL   
Clone 37.S1 
BioLegend 
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 Rat biotinylated anti-mouse CD4 and CD8  Stock 0.5mg/mL 
       Clones GK1.5 + 53-6.7, 
       BioLegend 
 Blocking Anti-FcγRII/III (= antiCD16/CD32)  HB-197 hybridoma cell 
supernatant   
Clone 2.4G2 
 SCF       conditioned medium from  
CHO/muSCF cells 
 Gentamicin      Sigma Aldrich 
 Anti-IgM       Jackson ImmunoResearch 
 B cell enrichment cocktail    BDBiosciences 
 Concanavalin A    Sigma Aldrich 
 Lipopolysaccarides, E.coli O55:B5    Sigma Aldrich 
 Dulbecco’s PBS 1x     PAA Laboratories GmbH 
 Normal Rat serum (NRS)    Bioconcept/Promocell 
 Streptavidin particles Plus-DM   BDBioSciences 
 MT.PBS plus trypan blue    Carl Roth 
 NH4Cl: Ammonium chloride   Sigma Aldrich 
 NaHCO3: Sodium bicarbonate   Sigma Aldrich 
 BSA: 7.5% Stock     Invitrogen 
 NaN3: 1M Stock in PBS    Sigma Aldrich 
 EDTA: 0.5 M pH8.0     Sigma Aldrich 
 Propidium iodide (PI), stock 500µg/mL  Sigma Aldrich 
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3.7 Protein extraction 
 
Cells 
Cells used for extraction were WT and bok-/- mast cells and activated T and B cells 
(see above)  
 
Protein extraction 
Total protein extracts were obtained by lysing cells in 50-100 µl (depending on the 
size of the cellular pellet) ONYX Buffer (20 mM Tris/HCl pH7.4, 135 mM NaCl, 1.5 
mM MgCl2. 1 mM EDTA, 1% Triton-X100, 10% glycerol plus protease inhibitor 
cocktail (Roche)). Cell pellets were well resuspended by pipetting and vortexing 
before tubes were placed for 15 minutes on ice. The lysate was then cleared by 
centrifugation for 10 min at 14000rpm, 4°C and the supernatant were transferred into 
a new Eppendorf tube.  
 
Protein quantitation with bicinchoninic acid (BCA) 
The concentration of total protein was determined by using the BCA kit following the 
manufacturer's protocol (Pierce Chemical Co., Rockford, IL). Protein samples were 
diluted 1:10 like the protocol recommended for microplate procedure. Absorbance 
was read at 562 nm in a multiplate spectrophotometer (SpectraMax M2, Bucher 
biotech) 
 
SDS-PAGE Gel Electrophoresis + Immunoblotting 
4x Lämmli buffer (0.25M Tris/HCl pH 6.8, 40% glycerol, 8% SDS, 0.016% 
Bromophenol Blue in ddH2O) plus DTT to a final concentration of 100 mM was added 
to the protein samples before denaturation at 95°C for 5 minutes. Samples were 
loaded onto to a 12.5% SDS-PAGE and electrophoresis performed at 100 V for 
approx 2 h (until front reached the bottom of the gel). The proteins were transferred 
to a methanol activated PVDF membrane (Immobilon-P, 0.45µm, Milipore) at 4°C, 
50V during 1 hour.  
For immunoprobing, the membranes were first blocked for at least 1 h in Blotto 
solution (5% skin milk powder in PBS + 0.1% Tween-20(PBS-T) and 10mM NaN3). 
After 3 wash steps in PBS-T, the membranes were probed with appropriate dilutions 
of primary antibody for 2h at room temperature. Membranes were washed 3x and 
then incubated with appropriate horse-radish peroxidase (HRPO) coupled secondary 
antibodies (diluted 1:20'000 in PBS-T + 5% milk). Membranes were very well washed 
(at least 3x 10 min) and the signals were detected by chemiluminescence (ECL kit, 
Pierce, ECL Luminata Forte, Millipore) and exposure to photosensitive films (ECL 
hyperfilm, GE Healthcare).  
 
Reagents 
 Protease Inhibitor cocktail 50x    Roche  
 Pepstatin 500x: Aspartate protease inhibitor  Sigma Aldrich 
 Dulbecco’s PBS 1x      PAA Laboratories GmbH 
 Glycerol       Sigma Aldrich 
 SDS        Sigma Aldrich 
 Bromophenol Blue      Carl Roth 
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 Milk powder fat free     Migros 
 Tris (= Trizma)      Sigma Aldrich 
 Glycine       Sigma Aldrich 
 Tween-20       Sigma Aldrich 
 Ammonium Persulfate for Electrophoresis  Sigma Aldrich 
 Tetramethylethylenediamine (TEMED)   Sigma Aldrich 
 PageRulerTM PLUS, prestained protein  Fermentas 
 
 SDS PAGE Running buffer 10x             1L 
0.25M Tris 
1.92M glycine 
1% SDS 
 
 SDS PAGE Transfer buffer 10x             1L 
250mM Tris 
1.92M glycine 
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4 INSTRUMENTS AND KITS 
 
The specific instruments and kit used in this project are listen in alphabetic order: 
 
 BD IMagTM, Cell Separation Magnet, 552311, Lot 04214, BD Biosciences 
 Cytospin3, Shandon, Dako Diagnostics AG 
 Developer machine for X-ray films, Kodak 
 FacsCalibur, BD Biosciences 
 Microcentrifugeuse Sorvall, Legend Micro 17, Thermo Scientific 
 Microscope Zeiss Axiplan, Carl Zeiss 
 Pierce® BCATM Protein Assay Kit, 23227, Lot JC121778, Thermo Scientific 
 Power pack, Consort 
 SDS-PAGE and Western blot equipment, Hoefer Inc 
 SpectraMax M2, Bucher Biotech, Basel 
 Thermocycler TECHNE, Genius 
 Thermomixer compact, Eppendorf 
 UVB Stratalinker 1800, Stratagene 
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5 RESULTS 
 
The main objective of this project was to highlight the role of Bok in cell proliferation 
and regulating cell cycle arrest. This approach was carried out on different types of 
primary or cultivated murine cells and several methods of analysis were performed. 
In addition, to obtain a statistical analysis, experiments were performed if possible at 
least in triplicates. 
 
5.1 Genotyping by polymerization chain reaction (PCR) 
 
The aim of this manipulation is to amplify a specific WT and mutant allele of bok to 
confirm the mice’s genotypes. To ensure the correct genotype of the mouse which 
was used for the experiments, tail-biopsies were collected post mortem and tested by 
PCR with 3 different primers: bok 17, bok 18 and bok 20. (Figure 14) 
 
 
Figure 14 : Schematic representation of the mouse bok locus of WT and bok-deficient mice with the 
position and orientation of the primers used for genotyping. 
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Because of mice’s DNA, the usual rules of sterility are not as strict as for human DNA 
(hood, adequate local). In addition, as the genotyping is only qualitative and not 
quantitative, the DNA quantification by spectrophotometer has not been performed. 
 
 
Figure 15 : Bok PCR genotyping results from 1.5% agarose gel electrophoresis.1. GeneRuler
TM
 100pb 
Plus DNA Ladder (Appendix 2) – 2. Negative control – 3. Wild Type Tail sample of 25.05.11 – 4. CS7/BL6 
(positive control for WT) – 5. Bok 
-/-
 Tail sample of 31.05.11 – 6. Bok#2 (positive control for bok
-/-
) – 7. Wild 
Type Tail sample of 31.05.11 
 
PCR amplification of genomic DNA extracted from Wild-Type and bok-/- animals 
confirmed the correct genotypes. On the gel (Figure 15), a clear-cut band was 
observed in 150pb for the Wild-Type allele and a band of 383 bp for the deleted allele 
of the bok-/- mice. In addition, these bands are perfectly similar to those of positive 
controls.  
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5.2 Colony forming assay in mouse embryo fibroblasts (MEF) 
 
In these experiments, the identification of colonies formed after 5 days was 
performed on 6-well plates. Three fibroblast lines, each derived from different 
embryos, were used for each genotype. These are all immortalized with an 
oncoprotein, SV40 large T antigen and have the characteristic to adhere to the plate 
after 2 hours already. Wildtype MEF represented by three separate embryos (E4, E5 
and E6) served as control. The bok-/ - MEF lines were derived from embryos E2, E5 
and E9. The following experiments were realized four times for each concentration of 
drugs (etoposide, hydroxyurea) or treatment (UV irradiation). 
 
According to Figure 16, a significant variation between independent lines of the same 
genotype is already visible before treatment. To obtain the survival colonies number, 
a relationship between treated and untreated cells is performed for each drug / 
irradiation. Therefore, this variation inter-embryo and inter-genotype (Figure 17) plays 
a significant role to interpret results.  
 
 
Figure 16 : bok
-/-
 or WT SV40 LT immortalized MEF were seeded at 1x10
3
 cells per well (6-well plate). After 
5 days, cells were fixed, stained with crystal violet and counted manually. Data are presented by means 
+/- SD of four experiments with three independent embryos of each genotype. 
 
 
Figure 17 : Comparison between untreated cells coming from WT and bok embryos. Data are represented 
by means +/- SD of four experiments with three independent embryos of each genotype. 
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Regarding the results obtained after normalization of the number of colony treated in 
function of the number of untreated colonies, the results of these four experiments 
with three independent embryos are represented graphically (Figure 18).  
 
 
Figure 18 : bok
-/-
 or WT SV40 immortalized MEF were seeded at 1x10
3
 cells per well (6-well plate) the day 
prior to UVB-irradiation with two different doses. The other wells were treated with two different doses per 
drug, including the DNA-damaging drug etoposide and the replicative stress inducing drug hydroxyurea.. 
After 5 days, cells were fixed, stained with crystal violet and counted manually. Data are presented as 
percentage of surviving colonies compared to the untreated controls; data are represented by means +/- 
SD of four experiments with three independent embryos of each genotype. 
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In Figure 18, two replicative stress-inducing drugs were tested on MEF cells. These 
substances are etoposide with a concentration of 0.2 and 1µg/mL and hydroxyurea 
with a concentration of 50 and 100µM. In view of the obtained results, there are more 
survival cells for WT cells than for bok-/-, except for the low concentration of 
hydroxyurea which is confirmed by Figure 19. In other words the loss of Bok does not 
increase survival after replicative stress-inducing drugs.  
 
DNA damage on MEF cells was also evaluated after UVB irradiation of 10 and 20 
J/m2. Both intensity of irradiation show no difference between the two genotypes 
although three embryos of the same genotype showed a wide variation between 
them. The same observation as replicative stress inducing drugs applies equally to 
this analysis that bok does not increase survival after DNA damage. 
 
 
Figure 19 : Comparison between cells coming from WT and bok embryos after different treatment: UVB 
irradiation, etoposide and hydroxyurea. Data are presented as percentage of surviving colonies 
compared to the untreated controls; data are represented by means +/- SD of four experiments with three 
independent embryos of each genotype. 
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In general, derived cells derived from embryos bok-/- survive less well than WT cells 
to radiation and drugs. Regarding the results obtained after UVB irradiation, the loss 
of Bok does not increase cell survival following DNA damage. The same observation 
applies equally to replicative stress-inducing drugs like etoposide and hydroxyurea. 
However, these observations are subjective, because of the large variation between 
embryos.  
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5.3 Direct competition growth in bone marrow derived Mast cells 
 
Mast cells are commonly involved in adaptive immune responses, especially during 
allergic and inflammatory reactions. In vivo, while they are still immature, they leave 
the bone marrow prior to localize in tissues where, under the influence of stem cell 
factor (SCF), they will differentiate and become mature. [22] In this experiment, these 
conditions were reproduced in vitro. With growth factors IL-3 and SCF, bone marrow 
derived progenitor cells were differentiated into mast cells in vitro for 4 weeks before 
using them for experiments. 
 
Previous data from Kaufmann’s lab indicated that bok-/- mast cells grow slower than 
WT cells when cultured in separate wells. In this experiment, this observation was 
also verified by mixing mast cells of two different genotypes in the same well. Cells 
can be distinguished from each other by their CD45 surface locus using FACS, as 
mast cells were derived from either CD45.1 or CD45.2 mice. The sum of CD45.1 and 
CD45.2 cells in a well always constitutes a total of 100%.  
 
 
Figure 20 : Mast cells competition result with 1% IL3 plus 1% SCF (left graph) and with 10% IL3 plus 10% 
SCF (right graph). Each mix contained 50% mast cells of each genotype at time 0. After various times of 
culturing, cells were washed and labelled by PE-labelled anti-CD45.1 and FITC-labelled anti-CD45.2 
antibodies and analyzed by FACS. Dead cells were excluded by PI staining. 
 
These experiments aimed at understanding the relationship between competition and 
cell growth. Figure 20 shows the evolution of the growth of mast cells over time with a 
cytokine concentration of 1% and 10%. A 50:50 starting mixture reveals first a 
preferential growth for CD45.2 phenotypes (bok -/-) during the first 48 hours. Indeed, 
the graph shows a faster growth for mast cells bok -/- than for WT during this period.  
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After one day, a difference of nearly 15% is observed between bok -/- and WT mast 
cells with the low concentration of cytokine. This difference is more pronounced with 
the high cytokines concentration (about 20%). For both cytokine concentrations, this 
trend is reversed after about 60 hours for low cytokine concentration and after more 
than 3 days for the 10% cytokine concentration. In this situation, WT grow faster than 
bok -/-. When the concentration of cytokines becomes limiting, bok -/- cells grow more 
slowly or are more sensitive to death induced by cytokine removal. This is supported 
by the observation that the decrease in growth for bok-/- at low cytokine 
concentrations (1%) is much more pronounced than at high cytokine concentrations 
(10%). 
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5.4 Cell cycle analysis  
 
 
Figure 21 : Results obtained for T cells hypo PI cell cycle analysis after 5 hours. (A) Untreated – (B) 
10µg/mL etoposide – (C) 100µM hydroxyurea 
 
The addition of drugs such as hydroxyurea plays a role in DNA synthesis and thus 
blocks the cell in S phase of the cell cycle. This substance is also used in the medical 
community to treat certain cancers or sickle cell anemia. [23] An accumulation of 
cells in G1 phase is then observed. The other substance tested here is etoposide, 
which affects topoisomerase II. This drug prevents the relinking step, initially 
performed by this enzyme and causes a definitive break through DNA strands. The 
cell cycle will be inhibited at the premitotic phase (late S and G2). [24] 
In this experiment, ConA activated T cells were tested with five different 
concentrations of etoposide (0.5, 1, 2.5, 5 and 10 μg/mL) and three hydroxyurea 
concentrations of 50, 100 and 200 μM. These tests were always performed in parallel 
to an untreated sample manipulated similarly to the others. Obtained results are 
shown in Figure 22. 
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Figure 22 : bok
-/-
 and WT T cells, activated by ConA, were left untreated, treated with different 
concentration of etoposide and hydroxyurea during 5 hours. Nuclear DNA was then stained with PI (using 
hypotonic buffer), and cell cycle profiles were analyzed by flow cytometry. Date represent means +/- SD of 
two independent experiments for each genotype 
 
To determine whether Bok is required for DNA damage-induced cell cycle arrest, 
analysis of T cells response with etoposide is realized. In Figure 22 cell arrest is 
slightly observed in the S or G2/M phase but no difference is observed between both 
genotypes. The cell cycle arrest was induced but it’s not very flagrant. The 
concentration of drugs is probably too low to affect cells. This does not allow 
concluding categorically that Bok is not required for DNA damage-induced cell cycle 
arrest. For the treatment of cells with the replicative-stress hydroxyurea, no arrest is 
really observed in S phase. Higher dose of drug must be tested. 
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Like for the T cells cycle experiment, the same analyses were performed on mast 
cells using etoposide concentrations of 0.1, 0.5 and 1 μg/mL. Like T cells, an 
untreated sample was made in parallel to other analysis to compare changes. 
 
 
Figure 23 : bok
-/-
 and WT mast cells were left untreated, treated with different concentration of etoposide 
during 72 hours. Nuclear DNA was then stained with PI (using hypotonic buffer), and cell cycle profiles 
were analyzed by flow cytometry. Date represent means +/- SD of three independent experiments for each 
genotype. 
 
Figure 23 shows that mast cells arrested in the G2/M phase after DNA damage 
exposure with etoposide. In return, percentage of cells in the G1 phase decreases 
following expansion of G2/M phase. .  
 Laetitia Roh  19.08.2011 
Bachelor Thesis  Page 44 
 
 
5.5 T cell activation 
 
This experiment is realized with splenic CD4+ and CD8+ T cells stimulated in vitro by 
different methods: mitogenic anti-CD3 antibody, anti-CD3 plus anti-CD28 antibodies 
or concanavalin A (ConA). The concentration of all stimuli was 10µg/mL. After a few 
hours, cells increased and eventually doubled in size regardless of cells type CD4+ or 
CD8+ (Figure 24). However, after 4 days, the size of CD8+ T cells decrease 
independently with the type of stimuli. A decrease in size is also observed with CD4+ 
cells after activation with ConA after the same period of culture. This can be 
explained by the depletion of the stimulus in the medium. In addition, T cell activation 
seems to occur more rapidly in the CD8 T cells than in CD4 T cells. 
 
 
Figure 24 : bok
-/-
 and WT resting T cells were activated with different stimuli: -CD3 antibody, -CD3 plus 
-CD28 antibodies or ConA. The relative cell size (forward light scatter: FSC) of activated T cells was 
determined by flow cytometry and is represented as mean FSC. Data show means +/- SD of two 
independent mice of each genotype 
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Regarding the two phenotypes, no difference between the increase of mean size 
(mean forward scatter of viable cells) of cells is observed during the early stages of 
activation between bok-/- and WT T cells.  
 
As mentioned above, following the activation, cells size can double or even triple. So, 
this phenomenon can be observed by light microscopy after performing cytospin 
(Figure 25). Fixation of cells is made with paraformaldehyde. As for staining, it 
requires two solutions: haematoxylin and eosin. Eosin, an acidic dye, highlights the 
basic parts such as the cytoplasm and haematoxylin stains the acidic parts of the cell 
(eg the nucleus) because it is a basic dye. 
 
 
Figure 25 : Pictures of T cells taken by microscopy before (left side) and after activation (right side) 
 
This time, figure 26 shows the number of cells after activation by the same stimuli as 
before. An enhanced growth for bok-/- T cells than WT after anti-CD3 and anti-
CD3/CD28 activation is observed. With concanavalin A, stimulation takes more time 
but the fold increase in cell number is higher. This results means that Bok can play 
an essential role in mitogen-induced cell proliferation but it is difficult to say precisely 
because the tests have been tried only 2 times. Triplicate experiments are necessary 
to obtain a reliable statistical study. 
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Figure 26 : bok
-/-
 and WT activated T cells were activated with different stimuli: -CD3 antibody, -
CD3/CD28 antibody or ConA. Percentages of cells were counted over time with reference beads by flow 
cytometry. Data represent means +/- SD of two independent experiments  
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5.6 B cell activation 
 
For B cells, similar experiments were realized in parallel of the T cell activation. In 
this case, different stimuli are used like LPS and IgM with a concentration of 
20µg/mL. Results are show in Figure 27. 
 
Like T cells, B cells increased you size with a factor of about 2 already after 24 hours 
incubation. Forward light scatter watch a reduction of cells size after 96 hours in both 
case, probably due to the exhaustion of the stimuli. 
 
 
Figure 27 : bok
-/-
 and WT activated B cells were activated with different stimuli: LPS or -IgM. The relative 
cell size (forward light scatter: FSC) of activated B cells was determined by flow cytometry and is 
represented as mean FSC. Data show means +/- SD of two independent mice of each genotype 
 
 
Figure 28 : Pictures of B cells taken by microscopy before (left) and after activation (right) 
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After in vitro stimulation, a dramatic expansion of cells occurs and modification of 
nucleus and cytoplasm can be observed after coloration of a cytospin. (Figure 28) 
The cell size can increase up to threefold.  
 
Like for T cell activation, viable cell number appears to increase more in bok-/- cells 
than other genotype (Figure 29). But unlike the experience with the LPS activation, a 
net growth peak is visible after 72 hours during B cell activation by anti-IgM before 
declining slowly. However, the standard deviation is quite high. To confirm these 
statements, it would be preferable to repeat the analysis at least once more to obtain 
3 independent readouts (n = 3).  
 
 
Figure 29 : bok
-/-
 and WT activated B cells were activated with different stimuli: LPS and -IgM. 
Percentages of cells were counted over time with reference beads by flow cytometry. Data represent 
means +/- SD of two independent experiments 
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5.7 Proteins extracts 
 
In order to visualize the protein Bok, proteins from B lymphocytes and mast cells 
were extracted directly from cultured cells. The extraction was done for each cellular 
pellet in a volume of extraction solution between 50 and 75 μL depending on the size 
of the pellet. In order to load the same amounts of samples on SDS-PAGE gels, 
protein concentrations of the extracts was quantified by a spectrophotometric method 
(BCA assay) at a dilution of 1/10 in duplicates. A calibration curve (standard curve 
using BSA) was also performed. The calculated calibration slope gave an equation of 
0.00119x - 0.0133 with a correlation coefficient of 0.99. With this calibration curve 
(Appendix 3) the concentrations of various samples can be defined with their 
absorbance (Table 2). 
 
Table 2: Results of quantification of proteins samples by spectrophotometry using the BCA assay 
Date Cell type Genotype 
Culture time 
 [h] 
Concentration 
 [µg/mL] 
28.06.11 B cell WT 0 1413.17 
28.06.11 B cell bok
-/- 0 1714.56 
29.06.11 B cell WT 24 1172.06 
29.06.11 B cell bok
-/- 24 1409.80 
30.06.11 B cell WT 48 2005.84 
30.06.11 B cell bok
-/- 48 2234.72 
17.06.11 Mast cell WT 5.1 0 2614.94 
17.06.11 Mast cell WT 5.2 0 5886.80 
17.06.11 Mast cell bok
-/- 0 3596.24 
27.06.11 Mast cell bok
-/- 0 9100.49 
28.06.11 Mast cell bok
-/- 24 10435.88 
29.06.11 Mast cell bok
-/- 48 9333.60 
30.06.11 Mast cell bok
-/- 72 9234.54 
27.06.11 Mast cell WT 0 10041.70 
28.06.11 Mast cell WT 24 7806.84 
29.06.11 Mast cell WT 48 9160.35 
30.06.11 Mast cell WT 72 8218.25 
 
In order to achieve homogeneity in the amount of loaded sample and therefore 
compare these bands, they were diluted to a concentration of 2µg/mL. 15 µl of each 
samples, corresponding to 30 µg per lane, were then subjected to electrophoretic 
separation on a 12.5% SDS-polyacrylamide gel. The different results obtained are 
illustrated in Appendix 4. 
 
The first two gels were loaded with the extracts from B cells and mast cells. The 
primary anti-Bok antibody revealed many non-specific bands between 28 and 55 kDa 
with a sharp band around 28 kDa. The theoretical molecular weight of Bok protein is 
22kDa. It is impossible to confirm its presence because no positive control is present 
but the nature of the sample used to look for another protein because it is as much 
as WT sample than bok-/- sample.  
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The anti-tubulin antibody allows verifying the similar protein loading. According to the 
comparable intensities of these bands, it can be concluded that similar amounts of 
protein extracts were loaded per lane, except for mast cells WT5.1 extract from 
17.06.2011, mast cells bok-/- extract from 17.06.2011 and mast cells bok-/- extract 
T72h from 30.06.2011 (Figure 34 Appendix 6) where no band is detectable. The 
bands correspond to 50 kDa and confirm the presence of the protein tubulin. Earlier 
incubation on the same gel with an anti-Bcl-2 antibody recognizes however a protein 
band at 25kDa, corresponding to the molecular weight of the protein Bcl-2. It can be 
concluded that the missing tubulin bands were likely degraded by proteolysis, either 
during sample preparation or in dying cells. [25] 
 
During the first test with the anti-Bok antibody, the results showed a band at 
approximately 28 kDa and no positive control could confirm the presence of Bok on 
the membrane. A second gel was run with extracts from B cells and a sample of 
hepatocytes has been added as a positive control. No sample gave a signal for Bok 
and the positive control only showed a low intensity band at around 22kDa, which 
corresponds to the size of Bok. Finally, the anti-Bim antibody was tested on the same 
membrane. The identification of a 25 kDa band confirms the presence of the protein 
Bim in the extracts [26], especially in mitogen-activated B cells. One residual gel 
could be stained and observed. Stained with Coomassie blue (Appendix 4), it shows 
again a homogeneity between the different extractions. 
 
Finally, a lack of protein may explain the absence of observed signal. Indeed, it is 
necessary to load a high amount of protein extract to see a strong band for Bok. The 
reason is that the rabbit polyclonal Bok-antibody, which was developed in the 
Kaufmann lab, has a rather low binding affinity and quite a few cross-reactive bands. 
However, it is to our knowledge the only antibody available that reliably detects Bok 
protein.  
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6 CONCLUSION AND PREVIEW 
 
At the end of these 16 weeks of experimental lab work, the requirements in the 
specifications have been performed successfully. This research is not yet complete 
but offers new ways for the role of Bok in the cell proliferation and cell cycle control 
based on obtained results. Observations of bok-deficient fibroblasts to DNA damage 
like UVB irradiation and other apoptotic stimuli (etoposide and hydroxyurea) show 
normal sensitivity. Although there is a significant variation between independent lines 
derived from different embryos of the same genotype, no difference appears between 
the averages of each genotype. It is likely that the observed variation between single 
lines of the same genotype is caused by the procedure of SV LT Ag transformation. 
This could be verified by performing similar experiments in primary MEFs (which can 
only be cultured in vitro for max 5 passages).  
 
Regarding the mast cells competition assay, it seems that bok-/- cells grow faster than 
WT during the first 2 or 3 days but when cytokine concentration is limiting, bok-/- cells 
either grow slower than WT or become more sensitive to death than WT cells. This 
faster growth (at early stage) is confirmed in the T and B cell experiments, where the 
fold increase of bok-/- activated lymphocytes is significantly greater than in WT 
controls. Moreover, cell cycle arrest analyses show that Bok is not necessary for 
DNA Damage-induced cell-cycle arrest or replicative stress in the cell types 
analyzed. This could also be explained by low endogenous of Bok in the cell types 
analyzed. Western blot analysis from proteins extracts of mast cells or activated B 
cells showed no detectable signal for Bok, indicating that Bok levels are indeed very 
low in those cell types. Given very low endogenous Bok protein expression in the 
cells analyzed, it is thus surprising and very interesting that some clear differences 
(e.g. in cell proliferation) could be identified in this project. Bigger differences might 
be found when analyzing cells from tissue like uterus, ovaries, brain or 
gastrointestinal tract (e.g. stomach, intestines, liver and pancreas) because qPCR 
analysis performed in the Kaufmann lab revealed that major bok expression is found 
there.  
 
Generally, it can be difficult to compare a knockout strain with a wild strain. Indeed, 
the total removal of a protein may result in a compensatory up- or downregulation of 
related (e.g. other Bcl-2 family members) or unrelated genes. The influence is difficult 
to quantify because the mechanism is unclear. That's why it would be beneficial to 
either re-introduce WT bok into bok-deficient cells (and use those as "WT controls") 
and/or to knockout bok conditionally in the adult mice. Alternatively, approaches with 
siRNA or shRNA, leading to a partial "knockdown" rather than complete "knockout" 
would be valuable tools to confirm the obtained findings. 
 
Other prospects for analysis of cellular stress are possible in the same focus, such as 
glucose deprivation in MEF and ER-stress in general (MEF, activated T and B cells, 
mast cells), as Bok has recently been identified to localize mainly to the membranes 
of the ER and associated membranes of the secretory system (unpublished 
observations by Nohemy Echeverry, Kaufmann lab).  
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9 APPENDIX 
 
Appendix 1: Protocols used during this project 
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Appendix 2: PCR marker 
 
 
Figure 30 : GeneRuler
TM
 100pb Plus DNA Ladder used for genotyping [27] 
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Appendix 3: Calibration curve for proteins quantification 
 
Table 3: Results of the calibration curve 
 Concentration 
[µg/mL] 
Absorbance 
Standard 1 2000 2.333 
Standard 2 1500 1.786 
Standard 3 1000 1.239 
Standard 4 750 0.930 
Standard 5 500 0.385 
Standard 6 250 0.315 
Standard 7 125 0.175 
Standard 8 25 0.026 
 
 
 
Figure 31 : Standard curve of bovin serum albumin (BSA) used for proteins quantification by 
spectrophotometry 
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Appendix 4: Coomassie gel from protein extracts 
 
 
Figure 32 : Gel control from B cells protein extract colored with Coomassie blue, 19.07.2011 
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Appendix 5: Western blot marker 
 
 
Figure 33 : Marker used for Western blot. PageRuler Plus prest. Prot Ladder, SM1811, Fermentas [27] 
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Appendix 6: Western blots from protein extracts 
 
 
 
 
Figure 34 : (A) Western blot from B and mast cell protein extracts revealed with anti-tubulin during 15 sec 
exposition, 08.07.2011. PageRuler Plus prest. Prot Ladder, SM1811, Fermentas (1) - Mast cells WT5.1 extract 
from 17.06.2011 (2) – Mast cells WT5.2 extract from 17.06.2011 (3) – Mast cells bok
-/-
 extract from 17.06.2011 (4) 
- Mast cells WT5.1 extract from 27.06.2011   (5) – Mast cells bok
-/-
 extract from 27.06.2011 (6) – B cells WT 
extract T0h from 28.06.2011 (7) – Mast cells bok
-/-
 extract T24h from 28.06.2011 (8) - Mast cells WT extract T24h 
from 28.06.2011  (9) B cells bok
-/-
 extract T0h from 28.06.2011 (10) (B)Western blot from B and mast cell 
protein extracts revealed with anti-tubulin during 15 sec exposition, 08.07.2011. PageRuler Plus prest. Prot 
Ladder, SM1811, Fermentas (1) - Mast cells WT extract T72h from 30.06.2011  (2) – Mast cells bok
-/-
 extract 
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T72h from 30.06.2011  (3) – Mast cells WT extract T48h from 29.06.2011 (4) - B cells WT extract T24h from 
29.06.2011 (5) – B cells bok
-/-
 extract T24h from 29.06.2011 (6) –Mast cells bok
-/-
 extract T48h from 29.06.2011 
(7) – B cells WT extract T48h from 30.06.2011 (8) - B cells bok
-/-
 extract T48h from 30.06.2011  (9) ddH2O (10) 
(C)Western blot from B and mast cell protein extracts revealed with anti-bok during 5 min exposition, 
08.07.2011. PageRuler Plus prest. Prot Ladder, SM1811, Fermentas (1) - Mast cells WT5.1 extract from 
17.06.2011 (2) – Mast cells WT5.2 extract from 17.06.2011 (3) – Mast cells bok
-/-
 extract from 17.06.2011 (4) - 
Mast cells WT5.1 extract from 27.06.2011   (5) – Mast cells bok
-/-
 extract from 27.06.2011 (6) – B cells WT extract 
T0h from 28.06.2011 (7) – Mast cells bok
-/-
 extract T24h from 28.06.2011 (8) - Mast cells WT extract T24h from 
28.06.2011  (9) B cells bok
-/-
 extract T0h from 28.06.2011 (10) (D) Western blot from B and mast cell protein 
extracts revealed with anti-bok during 5 min exposition, 08.07.2011. PageRuler Plus prest. Prot Ladder, 
SM1811, Fermentas (1) - Mast cells WT extract T72h from 30.06.2011  (2) – Mast cells bok
-/-
 extract T72h from 
30.06.2011  (3) – Mast cells WT extract T48h from 29.06.2011 (4) - B cells WT extract T24h from 29.06.2011 (5) 
– B cells bok
-/-
 extract T24h from 29.06.2011 (6) –Mast cells bok
-/-
 extract T48h from 29.06.2011 (7) – B cells WT 
extract T48h from 30.06.2011 (8) - B cells bok
-/-
 extract T48h from 30.06.2011  (9) ddH2O (10) 
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Figure 35 : (A) Western blot from B and mast cells protein extract revealed with anti-tubulin during 2 sec 
exposition, 14.07.2011. PageRuler Plus prest. Prot Ladder, SM1811, Fermentas (1) - Mast cells WT5.1 extract 
from 17.06.2011 (2) – Mast cells WT5.2 extract from 17.06.2011 (3) – Mast cells bok
-/-
 extract from 17.06.2011 (4) 
- Mast cells WT5.1 extract from 27.06.2011 (5) – Mast cells bok
-/-
 extract from 27.06.2011 (6) – B cells WT extract 
T0h from 28.06.2011 (7) – Mast cells bok
-/-
 extract T24h from 28.06.2011 (8) - Mast cells WT extract T24h from 
28.06.2011  (9) B cells bok
-/-
 extract T0h from 28.06.2011 (10) (B)Western blot from B and mast cells protein 
extract revealed with anti-tubulin during 2 sec exposition, 14.07.2011  PageRuler Plus prest. Prot Ladder, 
SM1811, Fermentas (1) - Mast cells WT extract T72h from 30.06.2011  (2) – Mast cells bok
-/-
 extract T72h from 
30.06.2011  (3) – Mast cells WT extract T48h from 29.06.2011 (4) - B cells WT extract T24h from 29.06.2011 (5) 
– B cells bok
-/-
 extract T24h from 29.06.2011 (6) –Mast cells bok
-/-
 extract T48h from 29.06.2011 (7) – B cells WT 
extract T48h from 30.06.2011 (8) - B cells bok
-/-
 extract T48h from 30.06.2011  (9) ddH2O (10) (C) Western blot 
from B and Mast cells protein extract revealed with anti-Bcl-2 during 4 min exposition,, anti-Bcl-2, 
14.07.2011 PageRuler Plus prest. Prot Ladder, SM1811, Fermentas (1) - Mast cells WT5.1 extract from 
17.06.2011 (2) – Mast cells WT5.2 extract from 17.06.2011 (3) – Mast cells bok
-/-
 extract from 17.06.2011 (4) - 
Mast cells WT5.1 extract from 27.06.2011   (5) – Mast cells bok
-/-
 extract from 27.06.2011 (6) – B cells WT extract 
T0h from 28.06.2011 (7) – Mast cells bok
-/-
 extract T24h from 28.06.2011 (8) - Mast cells WT extract T24h from 
28.06.2011  (9) B cells bok
-/-
 extract T0h from 28.06.2011 (10) (D) Western blot from B and Mast cells protein 
extract revealed with anti-Bcl-2 during 4 min exposition, 14.07.2011 PageRuler Plus prest. Prot Ladder, 
SM1811, Fermentas (1) - Mast cells WT extract T72h from 30.06.2011  (2) – Mast cells bok
-/-
 extract T72h from 
30.06.2011  (3) – Mast cells WT extract T48h from 29.06.2011 (4) - B cells WT extract T24h from 29.06.2011 (5) 
– B cells bok
-/-
 extract T24h from 29.06.2011 (6) –Mast cells bok
-/-
 extract T48h from 29.06.2011 (7) – B cells WT 
extract T48h from 30.06.2011 (8) - B cells bok
-/-
 extract T48h from 30.06.2011  (9) ddH2O (10) 
 
 
 
 
Figure 36 : (A) Western blot from B cells protein extract revealed with anti-bok during 5 min exposition, 
19.07.2011 PageRuler Plus prest. Prot Ladder, SM1811, Fermentas (1) - B cells WT extract T0h from 28.06.2011 
(2) - B cells bok
-/- 
extract T0h from 28.06.2011 (3) - B cells WT extract T24h from 29.06.2011 (4) – Hepatocyte 
extract (5) - B cells bok
-/- 
extract T24h from 29.06.2011 (6) - B cells WT extract T48h from 30.06.2011 (7) - B cells 
bok
-/- 
extract T48h from 30.06.2011 (8) - ddH2O (9) - ddH2O (10) (B) Western blot from B cells protein extract 
revealed with anti-tubulin during 5 sec exposition, 19.07.2011 PageRuler Plus prest. Prot Ladder, SM1811, 
Fermentas (1) - B cells WT extract T0h from 28.06.2011 (2) - B cells bok
-/- 
extract T0h from 28.06.2011 (3) - B 
cells WT extract T24h from 29.06.2011 (4) – Hepatocyte extract (5) - B cells bok
-/- 
extract T24h from 29.06.2011 
(6) - B cells WT extract T48h from 30.06.2011 (7) - B cells bok
-/- 
extract T48h from 30.06.2011 (8) - ddH2O (9) - 
ddH2O (10) 
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Figure 37 : (A) Western blot from B cells protein extract revealed with anti-Bim during 5 min exposition, 
20.07.2011. PageRuler Plus prest. Prot Ladder, SM1811, Fermentas (1) - B cells WT extract T0h from 
28.06.2011 (2) - B cells bok
-/- 
extract T0h from 28.06.2011 (3) - B cells WT extract T24h from 29.06.2011 (4) – 
Hepatocyte extract (5) - B cells bok
-/- 
extract T24h from 29.06.2011 (6) - B cells WT extract T48h from 30.06.2011 
(7) - B cells bok
-/- 
extract T48h from 30.06.2011 (8) - ddH2O (9) - ddH2O (10)  (B) Western blot from B cells 
protein extract revealed with anti-tubulin during 5 min exposition, 20.07.2011 PageRuler Plus prest. Prot 
Ladder, SM1811, Fermentas (1) - B cells WT extract T0h from 28.06.2011 (2) - B cells bok
-/- 
extract T0h from 
28.06.2011 (3) - B cells WT extract T24h from 29.06.2011 (4) – Hepatocyte extract (5) - B cells bok
-/- 
extract T24h 
from 29.06.2011 (6) - B cells WT extract T48h from 30.06.2011 (7) - B cells bok
-/- 
extract T48h from 30.06.2011 
(8) - ddH2O (9) - ddH2O (10)   
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Appendix 7: Fluorochromes 
 
Table 4: List of the most common used fluorochromes for flow cytometry [3] 
 
 
 
